Improving the limit of detection for Sanger sequencing: A comparison of methodologies for KRAS variant detection.
暂无分享,去创建一个
Emily Zeringer | J. Boonyaratanakornkit | K. Champion | Colin J Davidson | Kristen J Champion | Marie-Pierre Gauthier | Fawn Wang | Jerry Boonyaratanakornkit | Julie R Jones | Edgar Schreiber | E. Schreiber | Fawn Wang | Marie-Pierre Gauthier | E. Zeringer | C. Davidson
[1] A. Lièvre,et al. KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer. , 2006, Cancer research.
[2] W. Shackelford,et al. A New Technology for Mutation Detection , 2004, Annals of the New York Academy of Sciences.
[3] T. Frebourg,et al. Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy , 2007, British Journal of Cancer.
[4] Robert A. Weinberg,et al. Ras oncogenes: split personalities , 2008, Nature Reviews Molecular Cell Biology.
[5] P. Jares,et al. KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program , 2008, Virchows Archiv.
[6] A. Jimeno,et al. KRAS mutation: comparison of testing methods and tissue sampling techniques in colon cancer. , 2010, The Journal of molecular diagnostics : JMD.
[7] C. Borg,et al. A multiplex SNaPshot assay as a rapid method for detecting KRAS and BRAF mutations in advanced colorectal cancers. , 2011, Journal of Molecular Diagnostics.
[8] M. Loda,et al. Sensitive sequencing method for KRAS mutation detection by Pyrosequencing. , 2005, The Journal of molecular diagnostics : JMD.
[9] Jin Li,et al. Ice-COLD-PCR enables rapid amplification and robust enrichment for low-abundance unknown DNA mutations , 2010, Nucleic Acids Res..
[10] Z. Ronai,et al. K-ras mutation: early detection in molecular diagnosis and risk assessment of colorectal, pancreas, and lung cancers--a review. , 2000, Cancer detection and prevention.
[11] G. Qiao,et al. KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib , 2008 .
[12] Kathleen M Murphy,et al. Comparison of Sanger sequencing, pyrosequencing, and melting curve analysis for the detection of KRAS mutations: diagnostic and clinical implications. , 2010, The Journal of molecular diagnostics : JMD.
[13] Daniel J. Freeman,et al. A comparability study of 5 commercial KRAS tests , 2010, Diagnostic pathology.
[14] F. Cianchi,et al. High-resolution melting analysis for rapid detection of KRAS, BRAF, and PIK3CA gene mutations in colorectal cancer. , 2008, American journal of clinical pathology.
[15] F.A.M. Bordonaba,et al. Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer , 2009 .
[16] R. Berbeco,et al. Replacing PCR with COLD-PCR enriches variant DNA sequences and redefines the sensitivity of genetic testing , 2008, Nature Medicine.